• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Botulinum toxin in clinical practice.临床实践中的肉毒杆菌毒素。
J Neurol Neurosurg Psychiatry. 2004 Jul;75(7):951-7. doi: 10.1136/jnnp.2003.034702.
2
Botulinum toxin in movement disorders.肉毒杆菌毒素在运动障碍中的应用。
Semin Neurol. 2007 Apr;27(2):183-94. doi: 10.1055/s-2007-971171.
3
Clinical comparison of botulinum toxin in motor and autonomic disorders: Similarities and differences.肉毒杆菌毒素在运动和自主神经紊乱中的临床比较:异同点
Toxicon. 2015 Dec 1;107(Pt A):68-71. doi: 10.1016/j.toxicon.2015.07.001. Epub 2015 Jul 3.
4
Other noncosmetic uses of BOTOX.肉毒杆菌毒素的其他非美容用途。
Dis Mon. 2002 May;48(5):357-66. doi: 10.1053/mda.2001.25136.
5
Treatment of gastrointestinal sphincters spasms with botulinum toxin A.用A型肉毒杆菌毒素治疗胃肠道括约肌痉挛。
Toxins (Basel). 2015 May 29;7(6):1882-916. doi: 10.3390/toxins7061882.
6
[Indications and management of botulinum toxin].[肉毒杆菌毒素的适应症及管理]
Rev Neurol. 1999;29(2):157-62.
7
Therapeutic uses of botulinum toxin: from facial palsy to autonomic disorders.肉毒杆菌毒素的治疗用途:从面瘫到自主神经紊乱
Expert Opin Biol Ther. 2008 Jun;8(6):791-8. doi: 10.1517/14712598.8.6.791.
8
Botulinum toxin in motor disorders.肉毒杆菌毒素在运动障碍中的应用。
Curr Opin Neurol. 1999 Aug;12(4):447-56. doi: 10.1097/00019052-199908000-00012.
9
The use of botulinum toxin type-B in the treatment of patients who have become unresponsive to botulinum toxin type-A -- initial experiences.使用B型肉毒杆菌毒素治疗对A型肉毒杆菌毒素无反应的患者——初步经验。
Eur J Neurol. 2005 Dec;12(12):947-55. doi: 10.1111/j.1468-1331.2005.01095.x.
10
The use of botulinum toxin in head and face medicine: an interdisciplinary field.肉毒杆菌毒素在头面部医学中的应用:一个跨学科领域。
Head Face Med. 2008 Mar 10;4:5. doi: 10.1186/1746-160X-4-5.

引用本文的文献

1
Photobiomodulation as a Hypothetical Strategy to Reverse Botulinum Toxin Effects: Exploring the Neuroregenerative Mechanisms and Translational Potential.光生物调节作为一种逆转肉毒杆菌毒素作用的假说策略:探索神经再生机制及转化潜力。
Life (Basel). 2025 Jul 28;15(8):1206. doi: 10.3390/life15081206.
2
The Impact of Strength Changes on Active Function Following Botulinum Neurotoxin-A (BoNT-A): A Systematic Review.肉毒杆菌神经毒素A(BoNT-A)注射后力量变化对主动功能的影响:一项系统评价
Toxins (Basel). 2025 Jul 23;17(8):362. doi: 10.3390/toxins17080362.
3
Targeted degradation of α-Synuclein using an evolved botulinum toxin protease.利用进化的肉毒杆菌毒素蛋白酶对α-突触核蛋白进行靶向降解。
Proc Natl Acad Sci U S A. 2025 Apr;122(13):e2426745122. doi: 10.1073/pnas.2426745122. Epub 2025 Mar 24.
4
Neurotoxin-Derived Optical Probes for Elucidating Molecular and Developmental Biology of Neurons and Synaptic Connections : Toxin-Derived Optical Probes for Neuroimaging.用于阐明神经元和突触连接的分子与发育生物学的神经毒素衍生光学探针:用于神经成像的毒素衍生光学探针。
Mol Imaging Biol. 2024 Dec;26(6):912-925. doi: 10.1007/s11307-024-01954-6. Epub 2024 Sep 30.
5
Patient Characteristics and Real-World Use of Botulinum Toxins for the Treatment of Cervical Dystonia, Blepharospasm, and Hemifacial Spasm.患者特征及肉毒毒素治疗颈肌张力障碍、眼睑痉挛和半面痉挛的真实世界应用。
Toxins (Basel). 2024 Aug 16;16(8):362. doi: 10.3390/toxins16080362.
6
Model-based interspecies interpretation of botulinum neurotoxin type A on muscle-contraction inhibition.基于模型的A型肉毒杆菌神经毒素对肌肉收缩抑制作用的种间解释。
Biopharm Drug Dispos. 2024 Dec;45(4-6):190-200. doi: 10.1002/bdd.2398. Epub 2024 Jul 19.
7
Botulinum toxin therapy for isolated first dorsal interosseous muscle pain and hypertrophy: A case report.肉毒杆菌毒素治疗孤立性第一背侧骨间肌疼痛和肥大:一例报告。
Clin Case Rep. 2024 Jun 23;12(7):e9094. doi: 10.1002/ccr3.9094. eCollection 2024 Jul.
8
Intragastric Botulinum Toxin Injection and Botulism: An Alarm for Clinicians.胃内注射肉毒杆菌毒素与肉毒中毒:给临床医生的警示
Case Rep Crit Care. 2024 Apr 12;2024:8183127. doi: 10.1155/2024/8183127. eCollection 2024.
9
[An analysis of clinical efficacy of microvascular decompression for 21 inpatients suffering from primary hemifacial spasm].[21例原发性面肌痉挛患者微血管减压术的临床疗效分析]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024 May;38(5):372-375. doi: 10.13201/j.issn.2096-7993.2024.05.004.
10
The Role of Botulinum Toxin Type-A in Spasticity: Research Trends from a Bibliometric Analysis.A型肉毒毒素在痉挛中的作用:基于文献计量分析的研究趋势。
Toxins (Basel). 2024 Apr 9;16(4):184. doi: 10.3390/toxins16040184.

本文引用的文献

1
Abstracts of the 8th International Congress of Parkinson's Disease and Movement Disorders. June 14-17, 2004. Rome, Italy.第八届帕金森病与运动障碍国际大会摘要。2004年6月14日至17日。意大利罗马。
Mov Disord. 2004;19 Suppl 9:S1-S491. doi: 10.1002/mds.20167.
2
Treatment of cervical dystonia with botulinum toxin.肉毒杆菌毒素治疗颈部肌张力障碍
Mov Disord. 2004 Mar;19 Suppl 8:S109-15. doi: 10.1002/mds.20024.
3
Basic immunological aspects of botulinum toxin therapy.肉毒杆菌毒素治疗的基础免疫学方面
Mov Disord. 2004 Mar;19 Suppl 8:S68-84. doi: 10.1002/mds.20020.
4
Different types of botulinum toxin in humans.人类体内不同类型的肉毒杆菌毒素。
Mov Disord. 2004 Mar;19 Suppl 8:S53-9. doi: 10.1002/mds.20010.
5
Molecular targets of botulinum toxin at the mammalian neuromuscular junction.肉毒杆菌毒素在哺乳动物神经肌肉接头处的分子靶点。
Mov Disord. 2004 Mar;19 Suppl 8:S7-S16. doi: 10.1002/mds.20004.
6
Botulinum toxin and other new approaches to migraine therapy.肉毒杆菌毒素及偏头痛治疗的其他新方法。
Annu Rev Med. 2004;55:505-18. doi: 10.1146/annurev.med.55.091902.104440.
7
A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease.一项关于肉毒杆菌毒素B治疗帕金森病流涎的双盲安慰剂对照试验。
Neurology. 2004 Jan 13;62(1):37-40. doi: 10.1212/01.wnl.0000101713.81253.4c.
8
Dystonia: medical therapy and botulinum toxin.肌张力障碍:药物治疗与肉毒杆菌毒素
Adv Neurol. 2004;94:275-86.
9
Botulinum toxin A (Botox Cosmetic): a review of its use in the treatment of glabellar frown lines.A型肉毒杆菌毒素(保妥适):用于治疗眉间皱纹的综述
Am J Clin Dermatol. 2003;4(10):709-25. doi: 10.2165/00128071-200304100-00005.
10
Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia.原始型与现行型肉毒杆菌毒素治疗颈部肌张力障碍的疗效及免疫原性比较。
Neurology. 2003 Apr 8;60(7):1186-8. doi: 10.1212/01.wnl.0000055087.96356.bb.

临床实践中的肉毒杆菌毒素。

Botulinum toxin in clinical practice.

作者信息

Jankovic J

机构信息

Department of Neurology, Baylor College of Medicine, Houston, Texas 77030,USA.

出版信息

J Neurol Neurosurg Psychiatry. 2004 Jul;75(7):951-7. doi: 10.1136/jnnp.2003.034702.

DOI:10.1136/jnnp.2003.034702
PMID:15201348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1739107/
Abstract

Botulinum toxin, the most potent biological toxin, has become a powerful therapeutic tool for a growing number of clinical applications. This review draws attention to new findings about the mechanism of action of botulinum toxin and briefly reviews some of its most frequent uses, focusing on evidence based data. Double blind, placebo controlled studies, as well as open label clinical trials, provide evidence that, when appropriate targets and doses are selected, botulinum toxin temporarily ameliorates disorders associated with excessive muscle contraction or autonomic dysfunction. When injected not more often than every three months, the risk of blocking antibodies is slight. Long term experience with this agent suggests that it is an effective and safe treatment not only for approved indications but also for an increasing number of off-label indications.

摘要

肉毒杆菌毒素是最具毒性的生物毒素,已成为越来越多临床应用中的强大治疗工具。本综述关注肉毒杆菌毒素作用机制的新发现,并简要回顾其一些最常见的用途,重点是基于证据的数据。双盲、安慰剂对照研究以及开放标签临床试验均提供了证据表明,当选择合适的靶点和剂量时,肉毒杆菌毒素可暂时改善与肌肉过度收缩或自主神经功能障碍相关的病症。每三个月注射不超过一次时,产生阻断抗体的风险很小。长期使用该药物的经验表明,它不仅对已批准的适应症有效且安全,对越来越多的未获批准适应症也是如此。